-
Cost-Effectiveness of Talazoparib Plus Enzalutamide for HRR-Deficient Metastatic Castration-Resistant Prostate Cancer
Mar 10, 2025, 14:00 PM -
Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care
Mar 10, 2025, 14:00 PM -
National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey
Mar 10, 2025, 14:00 PM -
Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI
Mar 10, 2025, 14:00 PM -
Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources
Mar 10, 2025, 14:00 PM -
The Evolution of Language in Clinical Outcome Assessments- An Analysis of Source Wording Updates, Translation Updates, and the Need to Periodically Assess the Revelance of Linguistically Validated Translations
Mar 10, 2025, 14:00 PM -
Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study
Mar 10, 2025, 14:00 PM -
Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Gastric Cancer (GC) and Gastroesophageal Junction (GEJ) Adenocarcinoma
Mar 10, 2025, 14:00 PM -
Accelerating EHR Insights: NLP-Driven Data Abstraction in Gallbladder Cancer
Mar 10, 2025, 14:00 PM -
Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment
Mar 10, 2025, 14:00 PM -
Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines
Mar 10, 2025, 14:00 PM -
A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities
Mar 10, 2025, 14:00 PM -
Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA
Mar 10, 2025, 14:00 PM -
Ongoing Accelerated Approval Trends and What It Means for Patients
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
Mar 10, 2025, 14:00 PM
